Is Your Name Jewish Enough to Oppose New Iran Sanctions?
Mark A.R. Kleiman, a drug policy expert at the University of California at Los Angeles, whom I respect for the cold clarity of his analysis, became quite emotional earlier this week about a subject far afield from the one he usually studies: The new Iran sanctions bill percolating in the U.S. Senate.
The bill's main sponsors, New Jersey Democrat Robert Menendez and Illinois Republican Mark Kirk, believe that the threat of additional sanctions will help concentrate the attention of the Iranian regime as it heads into a new round of nuclear negotiations in Geneva. At this moment, passage of the bill, might actually derail negotiations and weaken the sanctions program already in place. (I wrote about my objections here.) Still, I understand the impetus behind such a bill: Additional sanctions might soon prove to be necessary during these negotiations, if the Iranians resist the demands of Western interlocutors to dismantle important components of their nuclear program.
